Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharma Publishes Q2 FY27 Unaudited Financial Results Ad
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 17 Nov 2026, 04:41 PM IST · BSE ID: 2918d4d0-faba-4f64-96e6-c1b193ec1f57
View Original BSE Filing (PDF)
💡
In Simple Terms
Aarey Drugs & Pharmaceuticals announced the publication of newspaper ads for its Q2 FY27 financial results.
🤖 AI Summary
- Aarey Drugs & Pharmaceuticals Ltd advertised unaudited standalone financial results for Q2 FY27 and half-year ended September 30, 2026.
- The Board of Directors approved these financial results in a meeting held on November 14, 2026.
- Publication of results advertisements was made in 'Active Times' (English) on November 17, 2026.
- Marathi newspaper 'Mumbai lakshadeep' also carried the financial results advertisement on November 16, 2026.
- The disclosure complies with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any immediate action based on this specific regulatory filing.
👤
Who Is Affected
All existing shareholders are informed of the public advertisement of the company's financial results, reinforcing transparency and regulatory compliance.
🔍
Management Signal
This action demonstrates management's adherence to SEBI Regulation 47 for timely public disclosure of financial results through advertisements.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Review detailed Q2 FY27 financial results for revenue and profit figures from the formal filing.
Monitor subsequent regulatory filings for any further operational or financial updates.
Track future Board meeting outcomes for potential announcements on business strategy.
LOW RISK
The filing is a procedural compliance update, presenting no new financial or operational risks.
💡 Investor Takeaway
Aarey Drugs & Pharmaceuticals Ltd has completed the procedural requirement of publishing newspaper advertisements for its unaudited standalone financial results for the quarter and half-year ended September 30, 2026 (Q2 FY27), as approved by the Board on November 14, 2026.
📅 Company Track Record
A previous filing on November 14, 2026, indicated Aarey Drugs reported Q2 FY27 net profit of Rs. 137.01 Lakhs and total income of Rs. 5,024.30 Lakhs, which this filing refers to as having been advertised.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What financial period do the published advertisements cover for Aarey Drugs?
The published advertisements cover the unaudited standalone financial results for the Second quarter and Half Year ended on September 30, 2026 (Q2 FY27).
Which newspapers carried the financial results advertisements for Aarey Drugs?
The financial results advertisements were published in 'Active Times' (English Newspaper) edition dated 17/11/2026 and 'Mumbai lakshadeep' (Marathi newspaper) edition dated 16/11/2026.
When did Aarey Drugs' Board of Directors approve these Q2 FY27 results?
The Board of Directors of Aarey Drugs & Pharmaceuticals Ltd considered, approved, and took on record the unaudited standalone financial results at their meeting held on Saturday, November 14, 2026.
Questions based on this BSE filing only. For information purposes.